Rankings
▼
Calendar
ACRS Q1 2022 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$435M
Q1 2022 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$1M
-18.2% YoY
Gross Profit
$298,000
20.5% margin
Operating Income
-$19M
-1301.2% margin
Net Income
-$19M
-1293.1% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
-3.2%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$227M
Total Liabilities
$46M
Stockholders' Equity
$180M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$2M
-18.2%
Gross Profit
$298,000
$575,000
-48.2%
Operating Income
-$19M
-$29M
+33.7%
Net Income
-$19M
-$29M
+34.7%
Revenue Segments
Contract research
$1M
84%
Other revenue
$232,000
16%
← FY 2022
All Quarters
Q2 2022 →